✓
Open
10 Aug 2026
✓
Close
12 Aug 2026
3
Allotment
—
✓
Listing
Mon, Aug 17, 2026
Price Band
₹768 to ₹807
Issue Size
1,16,46,246 shares (agg. up to ₹940 Cr)
Lot Size
18 Shares
Listing Date
Mon, Aug 17, 2026
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 49.35x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 2,148.42 | 1,461.56 | 1,221.06 |
| Total Income | 1,455.17 | 1,027.94 | 840.66 |
| Profit After Tax | 164.14 | 138.58 | 83.54 |
| EBITDA | 328.24 | 256.64 | 185.09 |
| NET Worth | 1,144.68 | 952.95 | 807.94 |
| Reserves and Surplus | 1,148.84 | 990.84 | 845.48 |
| Total Borrowing | 412.64 | 123.16 | 174.58 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Fabtech Technologies Ltd. | Mainboard | ₹230.30 Cr | ₹191 | 13.32 | ₹182.40 | -4.50% | ₹147.02 |
| Q-Line Biotech Ltd. | SME | ₹214.48 Cr | ₹343 | 20.82 | ₹474.60 | +38.37% | ₹726.20 |
| Earkart Ltd. | SME | ₹49.26 Cr | ₹135 | 20.48 | ₹142.25 | +5.37% | ₹127.05 |
| Galaxy Medicare Ltd. | SME | ₹22.31 Cr | ₹54 | 19.01 | ₹51.30 | -5.00% | ₹16.90 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure towards the setting up of infrastructure for research and development facility, Center of Excellence and connected office space. | 105.54 |
| 2 | Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and | 72.28 |
| 3 | General Corporate Purposes | 9.47 |
| 4 | Issue Expenses | 59.54 |
| Total | 246.83 |
About Molbio Diagnostics IPO
Updated on Sep 13, 2026
Contact Details
Molbio Diagnostics Ltd. AddressPlot No. L-46Phase II-D, Verna Industrial AreaVerna, SalceteSouth Goa, Goa, 4037228326724888investors@molbiodiagnostics.comVisit Website